Core Laboratory angiographic and Clinical Event Committee safety primary endpoints
| Core laboratory angiographic occlusion findings | Post-procedure | 12 Months | 12 Months |
| n=30 (95% CI) | n=27 (95% CI) | n=30 (95% CI) | |
| By available angiography | Imputed by LOCF* | ||
| Raymond class | |||
| Complete 100% occlusion (Class I) | 60.0% (18/30) (40.6% to 77.3%) | 92.6% (25/27) (75.7% to 99.1%) | 86.7% (26/30) (69.3% to 96.2%) |
| With no stenosis (≤50%) | 60.0% (18/30) (40.6% to 77.3%) | 88.9% (24/27) (70.8% to 97.6%) | 83.3% (25/30) (65.3% to 94.4%) |
| Residual neck† (Class II) | 26.7% (8/30) (12.3% to 45.9%) | 0.0% (0/27) (0.0% to 12.8%) | 0.0% (0/30) (0.0% to 11.6%) |
| Residual aneurysm‡ (Class III) | 10.0% (3/30) (2.1% to 26.5%) | 7.4% (2/27) (0.9% to 24.3%) | 10.0% (3/30) (2.1% to 26.5%) |
| Not assessable | 3.3% (1/30) (0.1% to 17.2%) | 0.0% (0/27) (0.0% to 12.8%) | 3.3% (1/30) (0.1% to 17.2%) |
| Parent artery stenosis | |||
| 0–25% | 100.0% (30/30) (88.4% to 100.0%) | 96.3% (26/27) (81.0% to 99.9%) | 93.3% (28/30) (77.9% to 99.2%) |
| 26–50% | 0.0% (0/30) (0.0% to 11.6%) | 0.0% (0/27) (0.0% to 12.8%) | 3.3% (1/30) (0.1% to 17.2%) |
| 51–70% | 0.0% (0/30) (0.0% to 11.6%) | 0.0% (0/27) (0.0% to 12.8%) | 0.0% (0/30) (0.0% to 11.6%) |
| 71–99% | 0.0% (0/30) (0.0% to 11.6%) | 3.7% (1/27) (0.1% to 19.0%) | 3.3% (1/30) (0.1% to 17.2%) |